BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8291902)

  • 1. Chemical pathology of homocysteine. I. Atherogenesis.
    McCully KS
    Ann Clin Lab Sci; 1993; 23(6):477-93. PubMed ID: 8291902
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chemical pathology of homocysteine. II. Carcinogenesis and homocysteine thiolactone metabolism.
    McCully KS
    Ann Clin Lab Sci; 1994; 24(1):27-59. PubMed ID: 8147567
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lipids and atherosclerosis.
    Choy PC; Siow YL; Mymin D; O K
    Biochem Cell Biol; 2004 Feb; 82(1):212-24. PubMed ID: 15052339
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Review and Hypothesis: Vulnerable plaque formation from obstruction of Vasa vasorum by homocysteinylated and oxidized lipoprotein aggregates complexed with microbial remnants and LDL autoantibodies.
    Ravnskov U; McCully KS
    Ann Clin Lab Sci; 2009; 39(1):3-16. PubMed ID: 19201735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Homocysteine and the pathogenesis of atherosclerosis.
    McCully KS
    Expert Rev Clin Pharmacol; 2015 Mar; 8(2):211-9. PubMed ID: 25653125
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Hyperhomocysteinemia: risk factor for premature atheromatosis].
    Wautrecht JC
    Rev Med Brux; 1997 Jun; 18(3):103-6. PubMed ID: 9273596
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Homocysteinylation of low-density lipoproteins (LDL) from subjects with Type 1 diabetes: effect on oxidative damage of human endothelial cells.
    Ferretti G; Bacchetti T; Rabini RA; Vignini A; Nanetti L; Moroni C; Mazzanti L
    Diabet Med; 2006 Jul; 23(7):808-13. PubMed ID: 16842488
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The influence of dietary vitamin E, fat, and methionine on blood cholesterol profile, homocysteine levels, and oxidizability of low density lipoprotein in the gerbil.
    Hidiroglou N; Gilani GS; Long L; Zhao X; Madere R; Cockell K; Belonge B; Ratnayake WM; Peace R
    J Nutr Biochem; 2004 Dec; 15(12):730-40. PubMed ID: 15607646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Modification with homocysteine does not increase susceptibility of human low-density lipoprotein to iron-mediated oxidation.
    Lynch SM
    Nutr Res; 2008 Sep; 28(9):615-9. PubMed ID: 19083467
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chemical pathology of homocysteine. V. Thioretinamide, thioretinaco, and cystathionine synthase function in degenerative diseases.
    McCully KS
    Ann Clin Lab Sci; 2011; 41(4):301-14. PubMed ID: 22166499
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hyperhomocysteinemia and arteriosclerosis: historical perspectives.
    McCully KS
    Clin Chem Lab Med; 2005; 43(10):980-6. PubMed ID: 16197285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Growth disorders and homocysteine metabolism.
    McCully KS
    Ann Clin Lab Sci; 1975; 5(3):147-52. PubMed ID: 1137342
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Protein homocysteinylation: a new mechanism of atherogenesis?
    Bełtowski J
    Postepy Hig Med Dosw (Online); 2005; 59():392-404. PubMed ID: 16106241
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Susceptibility of plasma low- and high-density lipoproteins to oxidation in patients with severe hyperhomocysteinemia.
    Córdoba-Porras A; Sánchez-Quesada JL; González-Sastre F; Ordóñez-Llanos J; Blanco-Vaca F
    J Mol Med (Berl); 1996 Dec; 74(12):771-6. PubMed ID: 8974018
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Homocysteine Metabolism, Atherosclerosis, and Diseases of Aging.
    McCully KS
    Compr Physiol; 2015 Dec; 6(1):471-505. PubMed ID: 26756640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of homocysteine on copper ion-catalyzed, azo compound-initiated, and mononuclear cell-mediated oxidative modification of low density lipoprotein.
    Halvorsen B; Brude I; Drevon CA; Nysom J; Ose L; Christiansen EN; Nenseter MS
    J Lipid Res; 1996 Jul; 37(7):1591-600. PubMed ID: 8827529
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Homocysteine and arteriosclerosis: established risk factor or new illusion?
    Djuric D; Wisotzki R; Mitrovic V
    Am J Ther; 2000 Nov; 7(6):381-7. PubMed ID: 11304646
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pathophysiological hypothesis of homocysteine thiolactone-mediated vascular disease.
    Jakubowski H
    J Physiol Pharmacol; 2008 Dec; 59 Suppl 9():155-67. PubMed ID: 19261978
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Homocysteine and its role in the pathogenesis of atherosclerotic vascular disease.
    Sainani GS; Sainani R
    J Assoc Physicians India; 2002 May; 50 Suppl():16-23. PubMed ID: 12186151
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Homocysteine and cardiovascular risk].
    Auer J; Berent R; Weber T; Lassnig E; Eber B
    Wien Med Wochenschr; 2001; 151(1-2):25-8. PubMed ID: 11234594
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.